Minireviews
Copyright ©The Author(s) 2017.
World J Nephrol. Jul 6, 2017; 6(4): 176-187
Published online Jul 6, 2017. doi: 10.5527/wjn.v6.i4.176
Table 3 Included studies on infectious diseases
Ref.Population/settingStudy designOverall study sizeAlbumin measurementHypoalbuminemia-related outcomes
AKI/ARFMortality
Prakash et al[22]HIVProspective, observational3540Albumin level at hospitalizationND2.14 g/dL in patients who died vs 3.2 g/dL in survivors; P < 0.001
Vannaphan et al[34]Severe falciparum malariaRetrospective, observational915Albumin < 3.5 g/dLAssociated with ARF (P < 0.001)ND
Lee et al[39]Acute viral hepatitis ARetrospective, observational391Albumin < 3.0 g/dLOR = 8.24 (95%CI: 2.53-26.86; P < 0.0001)ND
Lee et al[35]Scrub typhusRetrospective, observational246Admission albumin < 3.0 g/dL vs ≥ 3.0 g/dLIncreased rate of non-oliguric ARF (40.4% vs 11.1%; P < 0.001)ND
Mehra et al[40]Dengue feverRetrospective, observational223Admission Albumin levelLower albumin (2.65 g/dL) in patients with vs without AKI (3.09 g/dL; P < 0.001)ND
Vikrant et al[36]Scrub typhusRetrospective, observational174Admission albumin levelND2.4 g/dL in patients who died vs 2.9 g/dL in survivors; P < 0.001
Ceylan et al[41]Antibiotic therapyRetrospective, observational112Albumin level at start of colistin therapyLower albumin (2.4 g/dL vs 2.7 g/dL) predicts colistin-induced AKI: OR = 0.643 (95%CI: 0.415-0.994; P = 0.047)ND
Trimarchi et al[37]H1N1 pneumoniaRetrospective, observational22Albumin level at study inclusionNSARF in 10 of 12 deaths: 1.82 g/dL in patients who died vs 2.61 g/dL in survivors; P < 0.01